Seido Capital
Overview
Seido Capital is a Montreal-based venture capital firm that backs innovators in Life sciences and deep tech from pre-seed to IPO.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Innospera Pharma Inc. | May 2025 | Seed | Co-investor |
| Kabandy | Apr 2022 | VC Round | Lead |
| Ability Biotherapeutics | Jun 2024 | Seed | Co-investor |
| Reverb Therapeutics | Mar 2026 | VC Round | Co-investor |
| Specific Biologics | Nov 2026 | Series A | Co-investor |
For institutional investors. Book with your work email.
Key People
Lénaïs Maskens
Investor
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Seido Capital based?
Seido Capital is headquartered in Montreal, Canada.
When was Seido Capital founded?
Seido Capital was founded in 2003.
How many portfolio companies does Seido Capital have?
Seido Capital has 8 portfolio companies in Caplight's dataset.
What are some companies in Seido Capital's portfolio?
Portfolio companies visible on Caplight include Innospera Pharma Inc., Kabandy, Ability Biotherapeutics, Reverb Therapeutics, Specific Biologics.
What was Seido Capital's most recent investment shown here?
Seido Capital's most recent investment in this portfolio sample was in Specific Biologics in 2026.
What sectors does Seido Capital focus on?
Seido Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Real Estate & PropTech, Enterprise Software.
What company stages does Seido Capital focus on?
Stage focus information for Seido Capital is not publicly available.
What is Seido Capital's AUM?
Seido Capital's assets under management are estimated between $106.5M and $106.5M.